Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001880794-21-000003
Filing Date
2021-12-17
Accepted
2021-12-16 18:08:13
Documents
1
Effectiveness Date
2021-12-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7638
  Complete submission text file 0001880794-21-000003.txt   8657
Mailing Address 22 STRATHMORE ROAD NATICK MA 01760
Business Address 22 STRATHMORE ROAD NATICK MA 01760 857-675-1592
Attivare Therapeutics, Inc. (Filer) CIK: 0001880794 (see all company filings)

EIN.: 861598751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-412051 | Film No.: 211498986